NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring

被引：2
|
作者：
Wang, Peng [1 ]
Segal, Jeremy [1 ]
Drazer, Michael W. [2 ]
Venkataraman, Girish [1 ]
Arber, Daniel A. [1 ]
Gurbuxani, Sandeep [1 ]
机构：
[1] Univ Chicago, Dept Pathol, MC3083,5841 S Maryland Ave MC0008,5841 S Maryland, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL USA
来源：
EJHAEM | 2022年 / 3卷 / 03期
关键词：
HIGH-DOSE CYTARABINE; AML;
D O I：
10.1002/jha2.445
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：962 / 965
页数：4
相关论文
共 50 条
  • [31] Correlation of BCRP Expression to NPM1 Mutations in Acute Myeloid Leukemia
    Sohrabi, Tayebeh
    Ayatollahi, Hossein
    Rokni, Mohsen
    Houshmand, Samaneh
    Zafari, Zahra
    Sadeghian, Mohammad H.
    Keramati, Mohammad R.
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2018, 28 (03): : 180 - 186
  • [32] Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor
    Papadaki, Christina
    Dufour, Annika
    Seibl, Marlene
    Schneider, Stephanie
    Bohlander, Stefan K.
    Zellmeier, Evelyn
    Mellert, Gudrun
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (04) : 517 - 523
  • [33] Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
    Kroenke, Jan
    Schlenk, Richard
    Jensen, Kai-Ole
    Eiwen, Karina
    Habdank, Marianne
    Spaeth, Daniela
    Krauter, Juergen
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2008, 112 (11) : 260 - 260
  • [34] Acute myeloid leukemia with concurrent NPM1 and RUNX1 mutations
    Zuo, Zhuang
    Medeiros, L. Jeffrey
    Yin, C. Cameron
    LEUKEMIA RESEARCH REPORTS, 2023, 20
  • [35] Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene
    Jeziskova, Ivana
    Razga, Filip
    Toskova, Martina
    Dvorakova, Dana
    Timilsina, Shira
    Mayer, Jiri
    Racil, Zdenek
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 867 - 870
  • [36] Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia
    Christopher, Mary R.
    Nawas, Mariam T.
    Reagan, John L.
    BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 135 - 143
  • [37] NPM1 Mutations Are a Secondary Genetic Event in NPM1-Mutated Acute Myeloid Leukemia
    Patel, Jay L.
    Schumacher, Jonathan
    Szankasi, Philippe
    Frizzell, Kimberly
    Sorrells, Shelly
    Shen, Wei
    Clayton, Adam
    Jattani, Rakhi
    Kelley, Todd W.
    MODERN PATHOLOGY, 2017, 30 : 369A - 369A
  • [38] NPM1 Mutations Are a Secondary Genetic Event in NPM1-Mutated Acute Myeloid Leukemia
    Patel, Jay L.
    Schumacher, Jonathan
    Szankasi, Philippe
    Frizzell, Kimberly
    Sorrells, Shelly
    Shen, Wei
    Clayton, Adam
    Jattani, Rakhi
    Kelley, Todd W.
    LABORATORY INVESTIGATION, 2017, 97 : 369A - 369A
  • [39] Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia
    Leibundgut, Elisabeth Oppliger
    Porret, Naomi A.
    Muggli, Marianne Bienz
    Baumgartner, Heidi
    Dahlhaus, Meike
    Baerlocher, Gabriela M.
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 173 - 177
  • [40] Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
    Mariotti, Benedetta
    Meconi, Federico
    Palmieri, Raffaele
    De Bellis, Eleonora
    Lavorgna, Serena
    Ottone, Tiziana
    Martini, Vincenza
    Lo-Coco, Francesco
    Cicconi, Laura
    CASE REPORTS IN HEMATOLOGY, 2019,
12345